The low-density lipoprotein receptor-related protein 1 in inflammation

Current Opinion in Lipidology

Volumn 24, Issue 2, 2013, Pages 134-137

  May, Petra ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

atherosclerosis; inflammation; lipopolysaccharide; lipoprotein receptor; low density lipoprotein receptor related protein 1; phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CALRETICULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ALZHEIMER DISEASE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENDOCYTOSIS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; INTRACELLULAR SIGNALING; LIVER CIRRHOSIS; LIVER FIBROSIS; LUNG FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; RECEPTORS, LDL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84875228330     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32835e809c     Document Type: Review

References (21)

1. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008; 88: 887-918.
2. Boucher P, Gotthardt M, Li WP, et al. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003; 300: 329-332.
3. Zerbinatti CV, Wozniak DF, Cirrito J, et al. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the lowdensity lipoprotein receptor-related protein. Proc Natl Acad Sci U S A 2004; 101: 1075-1080.
4. Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113: 153-162.
5. Zurhove K, Nakajima C, Herz J, et al. Gamma-secretase limits the inflammatory response through the processing of LRP1. Sci Signal 2008; 1: ra15.
6. Moghimpour Bijani, F, Vallejo JG, Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int Rev Immunol 2012; 31: 379-395.
7. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-1332.
8. Jaeger LB, Dohgu S, Sultana R, et al. Lipopolysaccharide alters the bloodbrain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 2009; 23: 507-517.
9. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: A23-A31.
10. Pocivavsek A, Mikhailenko I, Strickland DK, et al. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation. J Neuroimmunol 2009; 214: 25-32.
11. Inubushi T, Kawazoe A, Miyauchi M, et al. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 2012; 287: 23527-23536.
12. Gorovoy M, Gaultier A, Campana WM, et al. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J Leukoc Biol 2010; 88: 769-778. The investigators demonstrate that the LRP1 extracellular domain, which is shed from the plasma membrane in the course of inflammtory events, modulates the inflammatory process through the activation of p38 and JNK.
13. Gaultier A, Arandjelovic S, Niessen S, et al. Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood 2008; 111: 5316-5325.
14. Yang YC, Zhang N, Van Crombruggen K, et al. Transforming growth factorbeta1 in inflammatory airway disease: a key for understanding inflammation and remodelling. Allergy 2012; 67: 1193-1202.
15. Boucher P, Li WP, Matz RL, et al. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodelling. PLoS One 2007; 2: e448.
16. Patel M, Morrow J, Maxfield FR, et al. The cytoplasmic domain of the low density lipoprotein (LDL) receptor-related protein, but not that of the LDL receptor, triggers phagocytosis. J Biol Chem 2003; 278: 44799-44807.
17. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, et al. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem 2002; 277: 11772-11779.
18. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194: 781-795.
19. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123: 321-334.
20. Fricker M, Oliva-Martin MJ, Brown GC. Primary phagocytosis of viable neurons by microglia activated with LPS or Abeta is dependent on calreticulin/LRP phagocytic signalling. J Neuroinflammation 2009; 9: 196.
21. Yancey PG, Blakemore J, Ding L, et al. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 2010; 30: 787-795.